o
ne misappropriated term making the rounds in dissident circles that really grinds my gears as an ostentatious pedant is the idea of the powers that be acting as social architects by implementing a strategy centered on the “Hegelian Dialectic.”
While the dynamic they’re describing — one in which crises are manufactured in order to push solutions which reorganize social structures under their hegemony — is an astute observation, the characterization of it as an application of Hegel’s dialectical methodology is incorrect. Hegel did not invent the principle of dialectics afterall, that is credited to Zeno of Elea, the 5th century BC Greek philosopher and founder of the Eleatic School, by Aristotle. Hegel’s contributions to the philosophy of dialectics would not be formulated until nearly 2 millennia later. While they were certainly poignant and have profound resonance on the modern study of dialectics, the system Hegel described does not meet the aforementioned description. Instead, that social engineering process of ascribing thesis > antithesis > synthesis as problem > reaction > solution is more accurately characterized as an example of the dialectic materialism of Karl Marx, which theorized that changing social conditions would facilitate a re-organization of society toward whatever goal those in power sought.
That philosophical diatribe aside, Moderna’s recent announcement of a new drug it is developing is a picturesque example of that problem > reaction > solution framework that many point to as evidence of a pre-existent elitist motive which masquerades behind the guise of a manufactured problem. Amidst a global surge in episodes of cardiac disease, Moderna has announced it is developing an mRNA shot that will be injected directly into the heart in order to stop myocardial infractions or to put it more bluntly: heart attacks.
Upon announcing the development of this mRNA “treatment” Moderna CEO Stéphane Bancel described it as “science fiction medicine.” before going on to taught the forthcoming significance of the shot by saying “We have now in the clinic a super exciting program where we inject mRNA into people’s hearts after a heart attack to grow back new blood vessels to help revascularize the heart,” The shots would rely on the same technology that Moderna utilized in the development of its COVID-19 vaccine, which Bancel also announced his company would be quadrupling the original price of to $130 per dose.
